您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Clopidogrel Chinese market report

讯：

Reserach report of Chinese Clopidogrel market 

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$1,500 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com 


Brief introduction

Clopidogrel is a Thienopyridine derivative, Antiplatelet drug,
 developed by Sanofi-Avetnis (brand name Plavix). Global sales revenue
 of Plavix reached to $5.9 billion in 2005, second best-selling product
 in the global market.Clopidogrel came into Chinese market in 2001,
 acquiring the most segment of the market of blood thinning drugs.

  With the expiration of Plavix's patents in 2006, Canada company
 Apotex launched the generic Clopidogrel, indicating the generic
 market opening. Now only a domestic company in China acquiring the
 approval for Clopidogrel except Sanofi-Avetnis, Clopidogrel market
 is charming for the pharmaceutical companies.

  The report presents the market scale and sales trend, market shares
 of different brands, region sales statistic etc for Clopidogrel. The
 market of blood thinning drugs in China is also presented in the
 report.


1、Summary
2 Different categories of blood thinning drugs
  2.1 Anticoagulant Drugs
  2.2 Antiplatelet drugs
  2.3 Others of Anticoagulant or Antiplatelet drugs
  2.4 Thrombolysis drugs
3 Sales analysis of blood thinning drugs from 2002 to 2005
  3.1 Market scale and growth trend
  3.2 Market share and change trend
    3.2.1 Sales shares of different products of Blood Thinning Drugs
    3.2.2 Sales shares of different products of Antiplatelet drugs
    3.2.3  Sales shares of different products of Anticoagulant Drugs
    3.2.4 Sales shares of different products of Thrombolysis drugs
  3.3 sales rank of different brands (enterprises)
4 Sales anlalysis of Clopidogrel in 2005
  4.1 Position of Clopidogrel in the market of blood thinning drugs
  4.2 Market shares of different brands (enterprises)
  4.3 Competition status of Clopidogrel in the past 4 years
    4.3.1 Sales values and growth trend
    4.3.2 Market shares of different strengths
    4.3.3 Market shares of different enterprises
5 Sales analysis of key cities
6 Information of researh and development for blood thinning drugs in
 the world
  6.1 Antiplatelet drugs
  6.2 Anticoagulant Drugs
7 Information of researh and development in China
  7.1 Domestic and import products marketed
  7.2 Situation of examination and approval for Clopidogrel